Gene expression of hENT1, dCK, CDA, dCMPD and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin

by Kulsoom B, Shamsi TS, Afsar NA
Published 2018-11-01

Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?

by Kulsoom B, Shamsi TS, Afsar NA, Memon Z, Ahmed N, Hasnain SN
Published 2018-03-01

Early and sustained deep molecular response achieved with nilotinib in high Sokal risk chronic myeloid leukemia patients

by Zaidi U, Kaleem B, Borhany M, Maqsood S, Fatima N, Sufaida G, Ansari SH, Farzana T, Shamsi TS
Published 2019-02-01